BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Ma S, Deng Y, Yi P, Yu J. Targeting the RNA m6A modification for cancer immunotherapy. Mol Cancer 2022;21:76. [PMID: 35296338 DOI: 10.1186/s12943-022-01558-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Kan Q, Ye Y, Qiu J, Huang L, Wu R, Yao C. Novel insight of N6-methyladenosine modified subtypes in abdominal aortic aneurysm. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1055396] [Reference Citation Analysis]
2 Pang Q, Chen H, Wu H, Wang Y, An C, Lai S, Xu J, Wang R, Zhou J, Xiao H. N6-methyladenosine regulators-related immune genes enable predict graft loss and discriminate T-cell mediate rejection in kidney transplantation biopsies for cause. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1039013] [Reference Citation Analysis]
3 Wang L, Luo S, Wang Z, Huang Y, Luo Y, Xie X. Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer. Journal of Immunology Research 2022;2022:1-14. [DOI: 10.1155/2022/5160705] [Reference Citation Analysis]
4 Zhang C, Zhang W, Shui Y, Li P, Tian Z, Duan S, Wei Q. Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1001506] [Reference Citation Analysis]
5 Jiang T, He X, Zhao Z, Zhang X, Wang T, Jia L. RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression. FASEB J 2022;36:e22618. [PMID: 36250924 DOI: 10.1096/fj.202200751RR] [Reference Citation Analysis]
6 Zhao J, Zou F, Zhu J, Huang C, Bu F, Zhu Z, Yuan R. Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis. Front Pharmacol 2022;13:1025618. [DOI: 10.3389/fphar.2022.1025618] [Reference Citation Analysis]
7 Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, Jin K, Wang L, Zhou J, Peng C, Tan Y, Ji J, Chen Z, Sun Q, Yang S, Tang J, Feng Y, Sun Y. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA.. [DOI: 10.21203/rs.3.rs-2107231/v1] [Reference Citation Analysis]
8 Zhou B, Bie F, Zang R, Zhang M, Song P, Liu L, Peng Y, Bai G, Zhao J, Gao S. RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer. eBioMedicine 2022;84:104268. [DOI: 10.1016/j.ebiom.2022.104268] [Reference Citation Analysis]
9 Liu S, Chen L, Zhang Y, Zhou Y, He Y, Chen Z, Qi S, Zhu J, Chen X, Zhang H, Luo Y, Qiu Y, Tao L, Zhu F. M6AREG: m6A-centered regulation of disease development and drug response. Nucleic Acids Res 2022:gkac801. [PMID: 36134713 DOI: 10.1093/nar/gkac801] [Reference Citation Analysis]
10 Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L, Wang Y, Fan R, Wang X, Shi Y. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther 2022;7:334. [PMID: 36138023 DOI: 10.1038/s41392-022-01175-9] [Reference Citation Analysis]
11 Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, Qian Y, Yang Z, Jiang X. Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01304-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Qi L, Zhang W, Ren X, Xu R, Yang Z, Chen R, Tu C, Li Z. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma. Front Immunol 2022;13:921223. [DOI: 10.3389/fimmu.2022.921223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]